Journal profile · Biochemistry & Molecular Biology
Frontiers in Bioscience-Landmark
ISSN 2768-6701 · eISSN 2768-6698 · IMR Press · Singapore · Monthly · Founded 1996
Frontiers in Bioscience-Landmark: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 3.95; fully open access; APC about USD 3,000; median 78 days to acceptance (139 articles, last 24 months); community-reported acceptance: about 46.25%; 380 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Frontiers in Bioscience-Landmark is published by IMR Press and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Ferroptosis and cancer prognosis, Cancer, Hypoxia, and Metabolism and Immune cells in cancer, together about 27% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Bioscience-Landmark (FBL) is an international, peer-reviewed, open-access bioscience journal focused on cellular and molecular biology. Founded in 1996, FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. The journal provides a platform for delivering scientific information to investigators, scientists, physicians, lecturers, and students. In addition to original research articles, FBL also considers other manuscript types such as reviews, systematic reviews, short communications, and editorials. Topics of interest include but are not limited to: Cell Cycle & Cell Death Signal Transduction & Cellular Communication Cytoskeleton & Cell Motility Membrane & Organelle Biology Stem Cells & Development Molecular Structure & Function Molecular and Cellular Biophysics Gene Expression & Regulation Cancer Biology Neurobiology Immunology & Inflammation Endocrinology & Metabolism Host-Pathogen Interactions Computational & Systems Biology Plant Biology Biotechnology
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editor-in-chief Graham PawelecPublisher website
Editorial board by country: 20 in mainland China (about 12%); most named United States 31, Italy 25, Mainland China 20, South Korea 12, Japan 7 (161 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Ferroptosis and cancer prognosisMedicine13.3%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology6.8%
- Immune cells in cancerImmunology and Microbiology6.8%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology5.8%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology5.2%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.6%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience3.9%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Cell Biology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.95LetPub ·
- Impact factor (publisher) 2025
- 4.1Publisher website ·
- CiteScore 2026-06
- 5.7LetPub ·
- CiteScore (publisher) 2025
- 5.7Publisher website ·
- SJR 2026-06
- 0.92LetPub ·
- SNIP 2026-06
- 0.74LetPub ·
- h-index
- 130LetPub ·
- h-index
- 43OpenAlex ·
- i10-index
- 558OpenAlex ·
- 2-year mean citedness
- 4.57OpenAlex ·
- Self-citation rate
- 4.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 361LetPub ·
Articles by year OpenAlex count · 1,979 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 311 | 311 | 103 |
| 2025 | 380 | 380 | 1,434 |
| 2024 | 430 | 430 | 3,589 |
| 2023 | 369 | 369 | 4,048 |
| 2022 | 339 | 339 | 5,110 |
| 2021 | 149 | 149 | 2,331 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
78 daysMedian, submission to acceptance · P25–P75 61 days – 99 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 139 articles with submission and acceptance dates (774 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 46.25%LetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to acceptance
- 75 daysPublisher website ·
- Submission to publication (journal-reported)
- about 19 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,000 | Yes | CC BY | |
| OpenAlex | USD 2,500 | — | — | |
| LetPub | USD 2,500 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 350 words
- Keywords
- ≥ 3
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- Templates
- Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional, 2
Article types accepted9
- comment/replyComment/Reply: Comment articles allow experts to comment on or criticize work previously published in the Journal.Length not stated
- commentaryCommentary: A Commentary is an article type written by one or more experts that highlights and discusses the most significant studies published in the Journal o…Length not stated
- conference reportConference Report: Conference reports are records of the events of a conference, seminar, or meeting.Length not stated
- editorialEditorial: Editorials are opinion articles from the editor or an invited author.Length not stated
- opinionOpinion: Opinion Articles allow authors to contribute viewpoints on the interpretation of recent findings in any research area, the value of the methods used, a…Length not stated
- original researchOriginal Research: The journal considers all original research manuscripts provided that the work reports scientifically sound experiments and provides a substa…Length not stated
- reviewReview: Reviews should be comprehensive overviews of a specific hot topic aligned with addressing specific aims and hypothesis through analyzing the latest lite…Length not stated
- short communicationShort Communication: Complete original research and/or clinical studies that do not require a full paper may be submitted as Short Communications.Length not stated
- systematic reviewSystematic Review: A Systematic Review is a type of literature review that uses systematic methods to collect secondary data, critically appraise research studi…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review
- Authorship 7. Authorship
According to the ICMJE guidelines, to qualify as an author a contributor should meet each of these four criteria: they have (i) made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and (ii) been involved in drafting the manuscript or reviewing it critically for important intellectual content; and (iii) given final approval of the …
Source ↗Publisher website ·- Conflicts of interest 10. Conflict of Interest
Authors, reviewers, and editors must declare whether there are any potential conflicts of interest (COIs) regarding the publication and handling of a study. Authors will declare their conflicts of interest in every published article and the name of Academic Editors who make the final decision will appear in published articles. The editors and peer reviewers should declare their COIs to the Editori…
Source ↗Publisher website ·- Publication ethics 6.2 Publication Ethics Statement
Follows COPE and ICMJE guidelines Model summary
FBL follows the guidelines of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.
Source ↗Publisher website ·- License & copyright 8. Copyright/Open Access
Starting from 2021, all FBL's content is available online, and is fully browsable and searchable. All FBL papers are published as Open Access articles under the unrestrictive CC-BY license. The copyright is retained by the author(s). IMR Press will insert the following note in the footer of the first page of the published text: © Year The Author(s). Published by IMR Press. This is an open access a…
Source ↗Publisher website ·- Open access 8. Copyright/Open Access
Open Access under CC-BY license; copyright retained by authors Model summary
Starting from 2021, all FBL's content is available online, and is fully browsable and searchable. All FBL papers are published as Open Access articles under the unrestrictive CC-BY license. The copyright is retained by the author(s). IMR Press will insert the following note in the footer of the first page of the published text: © Year The Author(s). Published by IMR Press. This is an open access a…
Source ↗Publisher website ·- Peer review 12. Editorial Process and Peer-Review
Editorial independence per WAME principles Model summary
IMR operates rigorous and transparent peer-review and editorial processes that aim to maximize quality. Peer review is handled by researchers and scholars. For more details, see our Editorial Process.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- IMR Press
- Country or region
- Singapore
- Language
- English
- Frequency
- Monthly
- Founded
- 1996
- ISSN
- 2768-6701
- Electronic ISSN
- 2768-6698
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Bioscience-Landmark
What CAS zone is Frontiers in Bioscience-Landmark in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Bioscience-Landmark is in Zone 4 of Biology, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Cell Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Bioscience-Landmark?
The latest impact factor listed by LetPub is 3.95; CiteScore 5.7, h-index 43.
How long does peer review take at Frontiers in Bioscience-Landmark?
Based on the dates recorded on 139 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 78 days (interquartile range 61–99 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 46.25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Bioscience-Landmark?
According to the journal's author guidelines: Abstract: ≤ 350 words; Keywords: ≥ 3; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; Templates: Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional, 2. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Bioscience-Landmark based?
Of the 161 board members whose country the journal's board page names, 20 (about 12%) are in mainland China; the countries named most often are United States (31), Italy (25) and Mainland China (20). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Bioscience-Landmark?
According to LetPub and DOAJ records, Frontiers in Bioscience-Landmark is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE; that list has not been checked against each database.
Is Frontiers in Bioscience-Landmark open access, and what is the APC?
Frontiers in Bioscience-Landmark is a fully open-access journal. APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .